[ALNY] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -3.81%
YoY- -18.13%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 29,907 21,899 37,924 17,096 15,932 18,960 17,454 43.33%
PBT -163,481 -141,276 -142,227 -122,937 -118,420 -107,290 -112,934 28.05%
Tax 79 -62 -7,949 -3,296 -2,577 -2,128 -5,217 -
NP -163,560 -141,214 -142,227 -122,937 -118,420 -107,290 -112,934 28.09%
Tax Rate - - - - - - - -
Total Cost 193,467 163,113 180,151 140,033 134,352 126,250 130,388 30.18%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -546.90 -644.84 -375.03 -719.10 -743.28 -565.88 -647.04 -10.63%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 -1.32 15.14%
EPS Diluted -1.63 -1.41 -1.48 -1.34 -1.34 -1.25 -1.32 15.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.